CompletedPhase 2NCT04264260

Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Principal Investigator
Zu Y Lin, MD
Kaohsiung Medical University
Intervention
Colchicine Tablets(drug)
Enrollment
42 target
Eligibility
20-85 years · All sexes
Timeline
20192025

Study locations (1)

Collaborators

Kaohsiung Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04264260 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma

← Back to all trials